Curs BNR — 12.11.2026 EUR 5,3459 USD 4,8155 GBP 6,3935

BIOFARM

96 articole · RSS

Biofarm To Buy Back 10% Of Own Shares By Public Offering
Capital Market

Biofarm To Buy Back 10% Of Own Shares By Public Offering

Romanian pharmaceutical producer Biofarm (BIO.RO) will buy back up to 10% of its own shares by public offering, at a price of RON0.305/share, thus, the value of the offering might reach RON3...

Gabriela Stan · 21.08.2014 · 12:51 · 1 min
Biofarm Net Profit Up 9% On Year In January-June
Health

Biofarm Net Profit Up 9% On Year In January-June

Romanian drugmaker Biofarm (BIO.RO) Thursday said its net profit rose 8.9% on the year to 14.74 million lei (EUR3.3 million) in the first half, on higher sales.

Florentina Dragu · 14.08.2014 · 18:57 · 1 min
Biofarm Net Profit Up 13% In 1Q, To RON10M
Health

Biofarm Net Profit Up 13% In 1Q, To RON10M

Romanian pharmaceutical producer Biofarm (BIO.RO) had sales of RON36.78 million in the first quarter, up 10% on the year, and a net profit of RON9.89 million, up 13% on the year, the company...

Oana Gavrila · 14.05.2014 · 19:25 · 1 min
SIFs Come To Hold 87% In Biofarm Stock
Capital Market

SIFs Come To Hold 87% In Biofarm Stock

Regional investment companies SIF Muntenia (SIF4.RO) and SIF Banat-Crisana (SIF1.RO), which owns 5% in former, took over 205.2 million Biofarm (BIO.RO) shares from the investors that subscri...

Catalina Apostoiu · 05.05.2014 · 14:55 · 1 min
SIF Muntenia To Launch Takeover Bid For 45.72% In Biofarm Next Week
Capital Market

SIF Muntenia To Launch Takeover Bid For 45.72% In Biofarm Next Week

Romanian regional investment fund SIF Muntenia (SIF4.RO), which controls jointly with SIF Banat-Crisana (SIF1.RO) 54.28% of the shares of pharmaceutical producer Biofarm (BIO.RO), will launc...

Ecaterina Craciun · 04.04.2014 · 12:21 · 1 min
Antibiotice, Biofarm or Zentiva: Which Pharma Stock To Invest In?
Capital Market

Antibiotice, Biofarm or Zentiva: Which Pharma Stock To Invest In?

Zentiva Bucuresti (SCD.RO) is paying the highest dividend of all pharmaceutical producers listed on the Bucharest stock market, while Biofarm (BIO.RO) will not be paying any. Analysts’ favor...

Loredana Frățilă-Cristescu · 26.03.2014 · 00:00 · 3 min
Biofarm 2014 Profit Seen Down 15% At RON21.7M
Health

Biofarm 2014 Profit Seen Down 15% At RON21.7M

Romanian pharmaceuticals company Biofarm (BIO.RO) targets a net profit of 21.7 million lei (EUR4.8 million) for 2014, down 15% on the year, and RON128 million sales (EUR28.4 million), up 9%...

Gabriela Stan · 13.03.2014 · 17:55 · 1 min
Biofarm Mulls 10% Share Buyback
Capital Market

Biofarm Mulls 10% Share Buyback

Romanian pharmaceuticals company Biofarm (BIO.RO) plans to launch a buyback program for up to 10% of its shares, the company said in a call to its shareholders Thursday.

Florentina Dragu · 13.03.2014 · 12:18 · 1 min
ASF Asks SIF Muntenia, SIF Banat-Crisana To Launch Takeover Bid For Biofarm
Capital Market

ASF Asks SIF Muntenia, SIF Banat-Crisana To Launch Takeover Bid For Biofarm

The Romanian Financial Supervisory Authority (ASF) asked regional investment funds SIF Muntenia (SIF4.RO) and SIF Banat-Crisana (SIF1.RO) to launch a takeover bid for pharmaceutical producer...

Gabriela Stan · 05.03.2014 · 11:26 · 1 min